306 related articles for article (PubMed ID: 31684858)
21. The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms.
Liu J; Wang F; Luo F
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671504
[TBL] [Abstract][Full Text] [Related]
22. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.
Zhao R; Hu Z; Zhang X; Huang S; Yu G; Wu Z; Yu W; Lu J; Ruan B
Cell Commun Signal; 2024 Jan; 22(1):68. PubMed ID: 38273295
[TBL] [Abstract][Full Text] [Related]
23. Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells.
Hernandez-Vargas H; Ouzounova M; Le Calvez-Kelm F; Lambert MP; McKay-Chopin S; Tavtigian SV; Puisieux A; Matar C; Herceg Z
Epigenetics; 2011 Apr; 6(4):428-39. PubMed ID: 21266853
[TBL] [Abstract][Full Text] [Related]
24. Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma.
Limberg J; Egan CE; Gray KD; Singh M; Loewenstein Z; Yang Y; Riascos MC; Al Asadi H; Safe P; El Eshaky S; Liang H; Ullmann TM; Wang W; Li W; Zhang T; Xiang J; Stefanova D; Jin MM; Zarnegar R; Fahey TJ; Min IM
Mol Cancer Res; 2023 May; 21(5):397-410. PubMed ID: 36790391
[TBL] [Abstract][Full Text] [Related]
25. The cross-talk between LncRNAs and JAK-STAT signaling pathway in cancer.
Hjazi A; Obaid RF; Ali SS; Abdullaev B; Alsaab HO; Huldani H; Romero-Parra RM; Mustafa YF; Hussien BM; Saadoon SJ
Pathol Res Pract; 2023 Aug; 248():154657. PubMed ID: 37451194
[TBL] [Abstract][Full Text] [Related]
26. Analysis of JAK-STAT signaling pathway genes and their microRNAs in the intestinal mucosa of genetically disparate chicken lines induced with necrotic enteritis.
Truong AD; Rengaraj D; Hong Y; Hoang CT; Hong YH; Lillehoj HS
Vet Immunol Immunopathol; 2017 May; 187():1-9. PubMed ID: 28494922
[TBL] [Abstract][Full Text] [Related]
27. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
Laurent C; Nicolae A; Laurent C; Le Bras F; Haioun C; Fataccioli V; Amara N; Adélaïde J; Guille A; Schiano JM; Tesson B; Traverse-Glehen A; Chenard MP; Mescam L; Moreau A; Chassagne-Clement C; Somja J; Escudié F; André M; Martin N; Lacroix L; Lemonnier F; Hamy AS; Reyal F; Bannier M; Oberic L; Prade N; Frénois FX; Beldi-Ferchiou A; Delfau-Larue MH; Bouabdallah R; Birnbaum D; Brousset P; Xerri L; Gaulard P
Blood; 2020 Jan; 135(5):360-370. PubMed ID: 31774495
[TBL] [Abstract][Full Text] [Related]
28. JAK-STAT and AKT pathway-coupled genes in erythroid progenitor cells through ontogeny.
Cokic VP; Bhattacharya B; Beleslin-Cokic BB; Noguchi CT; Puri RK; Schechter AN
J Transl Med; 2012 Jun; 10():116. PubMed ID: 22676255
[TBL] [Abstract][Full Text] [Related]
29. JAK-STAT signaling as an ARDS therapeutic target: Status and future trends.
Zhang Y; Gao Z; Jiang F; Yan H; Yang B; He Q; Luo P; Xu Z; Yang X
Biochem Pharmacol; 2023 Feb; 208():115382. PubMed ID: 36528067
[TBL] [Abstract][Full Text] [Related]
30. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
Coskun M; Salem M; Pedersen J; Nielsen OH
Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
[TBL] [Abstract][Full Text] [Related]
31. Evolution of JAK-STAT pathway components: mechanisms and role in immune system development.
Liongue C; O'Sullivan LA; Trengove MC; Ward AC
PLoS One; 2012; 7(3):e32777. PubMed ID: 22412924
[TBL] [Abstract][Full Text] [Related]
32. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
Groner B; von Manstein V
Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
[TBL] [Abstract][Full Text] [Related]
33. The regulation of JAKs in cytokine signaling and its breakdown in disease.
Hammarén HM; Virtanen AT; Raivola J; Silvennoinen O
Cytokine; 2019 Jun; 118():48-63. PubMed ID: 29685781
[TBL] [Abstract][Full Text] [Related]
34. Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer.
Rizwi FA; Abubakar M; Puppala ER; Goyal A; Bhadrawamy CV; Naidu VGM; Roshan S; Tazneem B; Almalki WH; Subramaniyan V; Rawat S; Gupta G
J Environ Pathol Toxicol Oncol; 2023; 42(4):15-29. PubMed ID: 37522565
[TBL] [Abstract][Full Text] [Related]
35. JAK-STAT signaling in cancer: From cytokines to non-coding genome.
Pencik J; Pham HT; Schmoellerl J; Javaheri T; Schlederer M; Culig Z; Merkel O; Moriggl R; Grebien F; Kenner L
Cytokine; 2016 Nov; 87():26-36. PubMed ID: 27349799
[TBL] [Abstract][Full Text] [Related]
36. A novel potential target of IL-35-regulated JAK/STAT signaling pathway in lupus nephritis.
Cai Z; Zhang S; Wu P; Ren Q; Wei P; Hong M; Feng Y; Wong CK; Tang H; Zeng H
Clin Transl Med; 2021 Feb; 11(2):e309. PubMed ID: 33634995
[TBL] [Abstract][Full Text] [Related]
37. JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition.
Luo Y; Alexander M; Gadina M; O'Shea JJ; Meylan F; Schwartz DM
J Allergy Clin Immunol; 2021 Oct; 148(4):911-925. PubMed ID: 34625141
[TBL] [Abstract][Full Text] [Related]
38. Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms.
Montero P; Milara J; Roger I; Cortijo J
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207510
[TBL] [Abstract][Full Text] [Related]
39. LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the JAK/STAT pathway.
Wang P; Peng X; Zhang J; Wang Z; Meng J; Cen B; Ji A; He S
Apoptosis; 2018 Dec; 23(11-12):651-666. PubMed ID: 30232656
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms and consequences of Jak-STAT signaling in the immune system.
Villarino AV; Kanno Y; O'Shea JJ
Nat Immunol; 2017 Mar; 18(4):374-384. PubMed ID: 28323260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
